- Home
- ANVS vs IH Comparison
ANVS vs IH Comparison
Compare ANVS & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- IH
- Stock Information
- Founded
- ANVS 2008
- IH 1996
- Country
- ANVS United States
- IH China
- Employees
- ANVS N/A
- IH N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- IH Other Consumer Services
- Sector
- ANVS Health Care
- IH Real Estate
- Exchange
- ANVS Nasdaq
- IH Nasdaq
- Market Cap
- ANVS 42.9M
- IH 146.3M
- IPO Year
- ANVS 2020
- IH 2020
- Fundamental
- Price
- ANVS $2.08
- IH $2.93
- Analyst Decision
- ANVS Strong Buy
- IH
- Analyst Count
- ANVS 4
- IH 0
- Target Price
- ANVS $17.33
- IH N/A
- AVG Volume (30 Days)
- ANVS 1.3M
- IH 15.3K
- Earning Date
- ANVS 11-07-2025
- IH 09-18-2025
- Dividend Yield
- ANVS N/A
- IH 3.15%
- EPS Growth
- ANVS N/A
- IH N/A
- EPS
- ANVS N/A
- IH 0.29
- Revenue
- ANVS N/A
- IH $123,215,612.00
- Revenue This Year
- ANVS N/A
- IH $39.02
- Revenue Next Year
- ANVS N/A
- IH N/A
- P/E Ratio
- ANVS N/A
- IH $9.44
- Revenue Growth
- ANVS N/A
- IH N/A
- 52 Week Low
- ANVS $1.11
- IH $1.47
- 52 Week High
- ANVS $10.54
- IH $3.60
- Technical
- Relative Strength Index (RSI)
- ANVS 48.51
- IH 52.71
- Support Level
- ANVS $1.57
- IH $2.68
- Resistance Level
- ANVS $2.21
- IH $3.01
- Average True Range (ATR)
- ANVS 0.17
- IH 0.18
- MACD
- ANVS 0.01
- IH -0.01
- Stochastic Oscillator
- ANVS 48.54
- IH 62.79
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.